The fight against antimicrobial resistance is one of the most urgent health battles of our time, and WHO Antimicrobial Resistance in Nigeria plays a vital role in guiding the country’s response. Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites evolve to resist the effects of medicines that once treated infections effectively. This resistance makes treatments less effective, leads to longer illnesses, and increases the risk of death.
In Nigeria, where infectious diseases remain a major cause of morbidity and mortality, antimicrobial resistance poses a severe threat to public health and national development. With support from the World Health Organization (WHO), the Nigerian government and health agencies are working together to strengthen surveillance, promote responsible antibiotic use, and ensure better infection control practices nationwide.
The Role of WHO in Combating AMR in Nigeria
The WHO Antimicrobial Resistance in Nigeria initiative supports the country in implementing strategic frameworks that align with the Global Action Plan (GAP) on Antimicrobial Resistance. This global plan, developed by WHO in partnership with the Food and Agriculture Organization (FAO) and the World Organisation for Animal Health (WOAH), outlines five key objectives:
Improving awareness and understanding of AMR.
Strengthening knowledge through surveillance and research.
Reducing infection incidence through effective hygiene and sanitation.
Optimizing the use of antimicrobial medicines.
Developing sustainable investment in countering AMR.
In Nigeria, these objectives are implemented through the National Action Plan on Antimicrobial Resistance (NAP 2.0 AMR), developed with technical assistance from WHO. This plan serves as a roadmap for combating AMR through a One Health approach, recognizing that human, animal, and environmental health are interconnected.
Through this partnership, WHO provides technical guidance, capacity building, and policy support to ensure Nigeria’s AMR response remains evidence-based and sustainable.
Understanding the Scale of the Problem
The challenge of WHO Antimicrobial Resistance in Nigeria is multifaceted. The misuse and overuse of antibiotics in humans, livestock, and agriculture have fueled the spread of resistant pathogens. In many communities, antibiotics are easily accessible without prescriptions, leading to self-medication and improper use.
Hospitals face similar challenges, with limited diagnostic facilities and inconsistent infection prevention measures. These gaps make it easier for resistant bacteria to spread within healthcare facilities and the community.
Data from WHO-supported AMR surveillance in Nigeria show a growing prevalence of resistant organisms such as Klebsiella pneumoniae, Staphylococcus aureus, and Escherichia coli. These bacteria are responsible for life-threatening infections that are increasingly difficult to treat with commonly available antibiotics.
Without urgent action, this crisis threatens to undermine decades of medical progress and make routine medical procedures, such as surgeries or childbirth, far more dangerous.
Building National Capacity Through Surveillance
A cornerstone of WHO Antimicrobial Resistance in Nigeria efforts is the strengthening of surveillance systems. WHO has supported Nigeria in developing the National AMR Surveillance Network, which connects major laboratories across the country to collect and analyze data on antibiotic resistance patterns.
This system is linked to the Global Antimicrobial Resistance and Use Surveillance System (GLASS), which allows Nigeria to share data with other countries and contribute to the global understanding of resistance trends.
Through this network, laboratories are trained to conduct standardized testing and report results accurately. These data guide national policies, ensuring that resources are directed toward the most pressing threats and that treatment guidelines reflect the current resistance patterns.
The partnership between WHO, the Nigerian Center for Disease Control and Prevention (NCDC), and the Nigerian National Antimicrobial Stewardship Taskforce (NNAST) ensures that Nigeria remains at the forefront of regional efforts to combat AMR through strong science and coordinated action.
Promoting Antimicrobial Stewardship and Awareness
Awareness and education are at the heart of WHO Antimicrobial Resistance in Nigeria initiatives. Each year, WHO partners with the Nigerian government, NCDC, and NNAST to lead World Antimicrobial Awareness Week (WAAW) a campaign dedicated to promoting responsible antibiotic use and increasing public understanding of AMR.
These campaigns emphasize that antibiotics should only be used with a doctor’s prescription, that full courses must be completed, and that antibiotics cannot treat viral infections like colds or flu.
Through WHO’s support, antimicrobial stewardship programs are being established across hospitals and clinics in Nigeria. These programs help healthcare workers use antibiotics appropriately, improving patient outcomes while reducing the risk of resistance.
By training doctors, pharmacists, and laboratory staff, WHO ensures that antimicrobial stewardship in Nigeria becomes a cornerstone of healthcare delivery rather than an afterthought.
One Health Approach to AMR
The WHO Antimicrobial Resistance in Nigeria strategy recognizes that human health is deeply connected to animal health and the environment. Overuse of antibiotics in livestock production contributes to resistant bacteria that can spread to humans through food, water, and direct contact.
To address this, WHO works closely with Nigeria’s ministries of health, agriculture, and environment to implement a One Health approach. This integrated strategy promotes responsible antibiotic use in both human and animal sectors while improving sanitation, vaccination, and biosecurity practices to reduce the need for antibiotics in the first place.
By promoting cross-sector collaboration, WHO ensures that Nigeria’s AMR response tackles the problem at every level of society.
Supporting Research and Innovation
Another major component of WHO Antimicrobial Resistance in Nigeria efforts is fostering local research and innovation. WHO encourages Nigerian scientists and institutions to study resistance mechanisms, discover new antimicrobial agents, and evaluate alternative therapies.
The organization also supports the development of rapid diagnostic tools that help clinicians identify infections quickly and choose the right treatments. With faster and more accurate diagnostics, the misuse of broad-spectrum antibiotics can be reduced significantly.
Additionally, WHO partners with academic institutions to support training programs in microbiology, epidemiology, and pharmacology building the next generation of experts who will lead Nigeria’s AMR response in the coming years.
Collaboration with NNAST and NCDC
The WHO Antimicrobial Resistance in Nigeria initiative thrives on strong partnerships with national stakeholders. The Nigerian Center for Disease Control and Prevention (NCDC) leads national coordination, ensuring that surveillance, policy, and response activities are aligned with WHO’s global framework.
At the same time, the Nigerian National Antimicrobial Stewardship Taskforce (NNAST) complements these efforts by promoting stewardship, public engagement, and professional training. Together, WHO, NCDC, and NNAST form a unified front against antimicrobial resistance, demonstrating that collaboration is key to success.
This partnership has already produced tangible results enhanced laboratory systems, stronger national awareness, and better integration between human and animal health programs.
The Road Ahead
While progress has been made, the battle against WHO Antimicrobial Resistance in Nigeria is far from over. Continued investment in healthcare infrastructure, surveillance, and education is essential to sustain momentum.
The focus must remain on improving antibiotic access and quality, enforcing prescription regulations, and promoting local production of effective, safe medicines. Public awareness campaigns should continue to educate communities on responsible antibiotic use and hygiene practices to prevent infections.
By sustaining collaboration between WHO, NCDC, NNAST, and international partners, Nigeria can build a future where antibiotics remain effective and lives are saved.
Conclusion
The WHO Antimicrobial Resistance in Nigeria initiative represents a vital partnership in the fight against one of the world’s greatest public health threats. Through surveillance, stewardship, education, and a One Health approach, WHO and Nigeria are laying the foundation for a sustainable and resilient healthcare system.
With continued support, awareness, and action, Nigeria can overcome the challenges of antimicrobial resistance and serve as a model for other nations in Africa and beyond. Together, WHO, NCDC, and NNAST are ensuring that the power of antibiotics is preserved for generations to come.
Select an element to maximize. Press ESC to cancel. Select an element to maximize. Press ESC to cancel.
